Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Possible role of human herpesvirus 6 as a trigger of autoimmune disease.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration.
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
The impact of microglial activation on blood-brain barrier in brain diseases.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis.
Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
Pages
« first
‹ previous
…
692
693
694
695
696
697
698
699
700
…
next ›
last »